GATC Health

We are proud to announce that GATC Health was featured on the Nasdaq Tower in Times Square, a powerful symbol of our commitment to innovation at the intersection of AI and biotechnology. As we mark this milestone, we’re also highlighting Derisq™, our proprietary AI report that helps de-risk drug development by delivering early insights into safety and efficacy before key decisions are made by biopharma and investors. Thank you to our incredible team, partners, and supporters. Your vision, dedication, and trust fuel our progress and drive us forward every day. Learn more about Derisq™ here: https://bit.ly/4n1W67j

Join biotech industry finance experts as they break down what AI really means for derisking investment in drug development. You’ll learn how investors and innovators are already applying AI to make smarter, safer decisions, and walk away with insights you can use right now. 📅 September 30, 2025 ⏰ 1 pm ET

GATC Health is heading to San Diego for the Precision in Clinical Trials Summit, October 12–13. Connect with our team to learn more about how GATC is helping life sciences organizations gain earlier insight into clinical risk and support more informed development decisions. Attending the summit? We’d welcome the opportunity to connect.

GATC Health will be in San Diego for the 30th Precision in Drug Discovery, Preclinical & Manufacturing Summit, October 15–16. Meet with our team to learn more about how GATC is helping life sciences organizations generate earlier insights to inform drug discovery and development decisions. Attending the summit? Connect with the GATC team while we’re in San Diego.

We’re headed to the polls - SXSW PanelPicker polls, that is. GATC Health’s proposed SXSW 2027 panel, “The End of the Lab Rat? How AI Is Rewriting Drug Development,” is now open for community voting. The discussion will examine a major shift underway in biomedical research: how AI and other human-relevant New Approach Methodologies could reduce reliance on animal models and what it will take for these technologies to earn the scientific, regulatory and public trust needed for broader adoption. If this is a conversation you’d like to see at #SXSW2027, we’d appreciate your vote. Vote here: https://lnkd.in/evFCz_8n Simply sign in or create a free SXSW account and click the heart to support the session. Voting is open through August 23. #SXSW2027 #PanelPicker #ArtificialIntelligence #DrugDevelopment #NAMs #Biotech

Attending BIO International Convention? Stop by Booth #1525 to learn how biotech organizations are using predictive AI to evaluate safety, efficacy, and development risk before clinical trials begin. The Derisq™ AI Report helps support more informed portfolio, development, and investment decisions by providing earlier insight into potential opportunities and risks.